383 related articles for article (PubMed ID: 29335545)
21. The role of PTEN in prostate cancer cell tropism to the bone micro-environment.
Wu Z; McRoberts KS; Theodorescu D
Carcinogenesis; 2007 Jul; 28(7):1393-400. PubMed ID: 17347137
[TBL] [Abstract][Full Text] [Related]
22. SKP2 loss destabilizes EZH2 by promoting TRAF6-mediated ubiquitination to suppress prostate cancer.
Lu W; Liu S; Li B; Xie Y; Izban MG; Ballard BR; Sathyanarayana SA; Adunyah SE; Matusik RJ; Chen Z
Oncogene; 2017 Mar; 36(10):1364-1373. PubMed ID: 27869166
[TBL] [Abstract][Full Text] [Related]
23. A rare castration-resistant progenitor cell population is highly enriched in Pten-null prostate tumours.
Sackmann Sala L; Boutillon F; Menara G; De Goyon-Pélard A; Leprévost M; Codzamanian J; Lister N; Pencik J; Clark A; Cagnard N; Bole-Feysot C; Moriggl R; Risbridger GP; Taylor RA; Kenner L; Guidotti JE; Goffin V
J Pathol; 2017 Sep; 243(1):51-64. PubMed ID: 28603917
[TBL] [Abstract][Full Text] [Related]
24. PTP1B Deficiency Enables the Ability of a High-Fat Diet to Drive the Invasive Character of PTEN-Deficient Prostate Cancers.
Labbé DP; Uetani N; Vinette V; Lessard L; Aubry I; Migon E; Sirois J; Haigh JJ; Bégin LR; Trotman LC; Paquet M; Tremblay ML
Cancer Res; 2016 Jun; 76(11):3130-5. PubMed ID: 27020859
[TBL] [Abstract][Full Text] [Related]
25. Targeted biallelic inactivation of Pten in the mouse prostate leads to prostate cancer accompanied by increased epithelial cell proliferation but not by reduced apoptosis.
Ma X; Ziel-van der Made AC; Autar B; van der Korput HA; Vermeij M; van Duijn P; Cleutjens KB; de Krijger R; Krimpenfort P; Berns A; van der Kwast TH; Trapman J
Cancer Res; 2005 Jul; 65(13):5730-9. PubMed ID: 15994948
[TBL] [Abstract][Full Text] [Related]
26. Tumor heterogeneity, aggressiveness, and immune cell composition in a novel syngeneic PSA-targeted Pten knockout mouse prostate cancer (MuCaP) model.
van Duijn PW; Marques RB; Ziel-van der Made ACJ; van Zoggel HJAA; Aghai A; Berrevoets C; Debets R; Jenster G; Trapman J; van Weerden WM
Prostate; 2018 Sep; 78(13):1013-1023. PubMed ID: 30133757
[TBL] [Abstract][Full Text] [Related]
27. Conditional expression of PTEN alters the androgen responsiveness of prostate cancer cells.
Wu Z; Conaway M; Gioeli D; Weber MJ; Theodorescu D
Prostate; 2006 Jul; 66(10):1114-23. PubMed ID: 16637073
[TBL] [Abstract][Full Text] [Related]
28. MYC Drives Pten/Trp53-Deficient Proliferation and Metastasis due to IL6 Secretion and AKT Suppression via PHLPP2.
Nowak DG; Cho H; Herzka T; Watrud K; DeMarco DV; Wang VM; Senturk S; Fellmann C; Ding D; Beinortas T; Kleinman D; Chen M; Sordella R; Wilkinson JE; Castillo-Martin M; Cordon-Cardo C; Robinson BD; Trotman LC
Cancer Discov; 2015 Jun; 5(6):636-51. PubMed ID: 25829425
[TBL] [Abstract][Full Text] [Related]
29. Coactivator SRC-2-dependent metabolic reprogramming mediates prostate cancer survival and metastasis.
Dasgupta S; Putluri N; Long W; Zhang B; Wang J; Kaushik AK; Arnold JM; Bhowmik SK; Stashi E; Brennan CA; Rajapakshe K; Coarfa C; Mitsiades N; Ittmann MM; Chinnaiyan AM; Sreekumar A; O'Malley BW
J Clin Invest; 2015 Mar; 125(3):1174-88. PubMed ID: 25664849
[TBL] [Abstract][Full Text] [Related]
30. Combined Loss of EAF2 and p53 Induces Prostate Carcinogenesis in Male Mice.
Wang Y; Pascal LE; Zhong M; Ai J; Wang D; Jing Y; Pilch J; Song Q; Rigatti LH; Graham LE; Nelson JB; Parwani AV; Wang Z
Endocrinology; 2017 Dec; 158(12):4189-4205. PubMed ID: 29029019
[TBL] [Abstract][Full Text] [Related]
31.
Huang SY; Huang GJ; Wu HC; Kao MC; Huang WC
Molecules; 2018 Oct; 23(10):. PubMed ID: 30301150
[TBL] [Abstract][Full Text] [Related]
32. HER2 overcomes PTEN (loss)-induced senescence to cause aggressive prostate cancer.
Ahmad I; Patel R; Singh LB; Nixon C; Seywright M; Barnetson RJ; Brunton VG; Muller WJ; Edwards J; Sansom OJ; Leung HY
Proc Natl Acad Sci U S A; 2011 Sep; 108(39):16392-7. PubMed ID: 21930937
[TBL] [Abstract][Full Text] [Related]
33. Pten dose dictates cancer progression in the prostate.
Trotman LC; Niki M; Dotan ZA; Koutcher JA; Di Cristofano A; Xiao A; Khoo AS; Roy-Burman P; Greenberg NM; Van Dyke T; Cordon-Cardo C; Pandolfi PP
PLoS Biol; 2003 Dec; 1(3):E59. PubMed ID: 14691534
[TBL] [Abstract][Full Text] [Related]
34. Prostate targeting: PSP94 gene promoter/enhancer region directed prostate tissue-specific expression in a transgenic mouse prostate cancer model.
Gabril MY; Onita T; Ji PG; Sakai H; Chan FL; Koropatnick J; Chin JL; Moussa M; Xuan JW
Gene Ther; 2002 Dec; 9(23):1589-99. PubMed ID: 12424611
[TBL] [Abstract][Full Text] [Related]
35. Jagged1 upregulation in prostate epithelial cells promotes formation of reactive stroma in the Pten null mouse model for prostate cancer.
Su Q; Zhang B; Zhang L; Dang T; Rowley D; Ittmann M; Xin L
Oncogene; 2017 Feb; 36(5):618-627. PubMed ID: 27345403
[TBL] [Abstract][Full Text] [Related]
36. Serum cholesterol levels and tumor growth in a PTEN-null transgenic mouse model of prostate cancer.
Allott EH; Masko EM; Freedland AR; Macias E; Pelton K; Solomon KR; Mostaghel EA; Thomas GV; Pizzo SV; Freeman MR; Freedland SJ
Prostate Cancer Prostatic Dis; 2018 Jun; 21(2):196-203. PubMed ID: 29795142
[TBL] [Abstract][Full Text] [Related]
37. Senescence Reprogramming by TIMP1 Deficiency Promotes Prostate Cancer Metastasis.
Guccini I; Revandkar A; D'Ambrosio M; Colucci M; Pasquini E; Mosole S; Troiani M; Brina D; Sheibani-Tezerji R; Elia AR; Rinaldi A; Pernigoni N; Rüschoff JH; Dettwiler S; De Marzo AM; Antonarakis ES; Borrelli C; Moor AE; Garcia-Escudero R; Alajati A; Attanasio G; Losa M; Moch H; Wild P; Egger G; Alimonti A
Cancer Cell; 2021 Jan; 39(1):68-82.e9. PubMed ID: 33186519
[TBL] [Abstract][Full Text] [Related]
38. Cooperation between FGF8b overexpression and PTEN deficiency in prostate tumorigenesis.
Zhong C; Saribekyan G; Liao CP; Cohen MB; Roy-Burman P
Cancer Res; 2006 Feb; 66(4):2188-94. PubMed ID: 16489020
[TBL] [Abstract][Full Text] [Related]
39. Heterogeneous tumor evolution initiated by loss of pRb function in a preclinical prostate cancer model.
Hill R; Song Y; Cardiff RD; Van Dyke T
Cancer Res; 2005 Nov; 65(22):10243-54. PubMed ID: 16288012
[TBL] [Abstract][Full Text] [Related]
40. Oncogene miR-106a promotes proliferation and metastasis of prostate cancer cells by directly targeting PTEN in vivo and in vitro.
Luo B; Kang N; Chen Y; Liu L; Zhang Y
Minerva Med; 2018 Feb; 109(1):24-30. PubMed ID: 28889725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
